Always follow these types of results since my father had Alzheimer's... a .45 benefit on a scale of 18 does not exactly get me excited though.
On Wednesday, September 28, 2022 at 9:23:52 PM UTC+10 [email protected] wrote: > Check out this article from The New York Times. Because I'm a subscriber, > you can read it through this gift link without a subscription. > > Alzheimer’s Drug Slows Cognitive Decline in Key Study > > Biogen and Eisai reported the finding from a large late-stage clinical > trial of lecanemab, a drug they are developing. > > > https://www.nytimes.com/2022/09/27/business/alzheimers-drug-biogen-lecanemab.html?unlocked_article_code=rsZSU2JmKGGy-_Exjmzb0hw2EMcmJiJYnwt1zMbDTejar-vnrnx0fQcD2v-PMNM_UJcVnoAflP6dsRoEug0g5r9dtMCLUxH9-ds6NjY0w-GEKrFHIIjqJ14Iaey6_w0tFTT4TN7kPOskkIHKeVA63t-ksQLAuUAVKhi6_n2EXmucOinMb-tT5kfVPQyw5a7Mal4GtemM_52b1wWOXEAWXU6TM356bxYRlZfEHoz76nmCZI7PijXZSJUsw8oqOi7DhWw_ieq64o02NJrv94QCFsX9_A6v771VDrcnedpoRUmV_ZDQVeSm_bjBTRsgdL2bPwsEhpVDpuJ6AFGhXPlkgizMunPd8OMUrylq&smid=em-share > -- You received this message because you are subscribed to the Google Groups "Everything List" group. To unsubscribe from this group and stop receiving emails from it, send an email to [email protected]. To view this discussion on the web visit https://groups.google.com/d/msgid/everything-list/febfee92-ca7e-4b0b-be36-a02a3ecd4201n%40googlegroups.com.
